TYCC
GOSS icon

Texas Yale Capital Corp’s Gossamer Bio GOSS Stock Holding History

Texas Yale Capital Corp’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-125
Closed -$31K – 511
2025
Q4 		$31K Hold
125
– – ﹤0.01% 490
2025
Q3 		$26.3K Hold
125
– – ﹤0.01% 479
2025
Q2 		$12.3K Hold
125
– – ﹤0.01% 464
2025
Q1 		$11K Hold
125
– – ﹤0.01% 449
2024
Q4 		$9.05K Buy
+125
New +$8.57K ﹤0.01% 460
2024
Q3 		– Sell
-125
Closed -$9.01K – 460
2024
Q2 		$9.01K Hold
125
– – ﹤0.01% 440
2024
Q1 		$11.8K Hold
125
– – ﹤0.01% 442
2023
Q4 		$9.13K Hold
125
– – ﹤0.01% 433
2023
Q3 		$8.33K Hold
125
– – ﹤0.01% 422
2023
Q2 		$12K Hold
125
– – ﹤0.01% 440
2023
Q1 		$12.6K Hold
125
– – ﹤0.01% 449
2022
Q4 		$21.7K Buy
+125
New +$82.3K ﹤0.01% 448
2022
Q1 		– Sell
-125
Closed -$113K – 479
2021
Q4 		$113K Hold
125
– – 0.01% 453
2021
Q3 		$126K Hold
125
– – 0.01% 442
2021
Q2 		$81K Buy
+125
New +$86.7K ﹤0.01% 460

Other funds holding GOSS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Texas Yale Capital Corp's GOSS Position: Q1 2026 in Review

Texas Yale Capital Corp sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 125 shares — an estimated $31K sold.

Texas Yale Capital Corp first reported a position in GOSS in Q2 2021 and held it in 15 quarters. The position peaked at $126K in Q3 2021. 181 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Texas Yale Capital Corp reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Texas Yale Capital Corp sold 125 Gossamer Bio shares in Q1 2026, an estimated $31K.
  • Texas Yale Capital Corp first reported a position in Gossamer Bio in Q2 2021 and held it in 15 quarters.
  • Texas Yale Capital Corp's Gossamer Bio position peaked at $126K in Q3 2021.
  • 181 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Texas Yale Capital Corp's 13F filing for Q1 2026, filed 4 May 2026.